BGM Group (NASDAQ:BGM) Sees Unusually-High Trading Volume – What’s Next?

BGM Group Ltd. (NASDAQ:BGM) saw strong trading volume on Wednesday . 38,025 shares changed hands during trading, an increase of 309% from the previous session’s volume of 9,307 shares.The stock last traded at $9.2960 and had previously closed at $9.64.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of BGM Group in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

BGM Group Price Performance

The firm has a 50 day moving average of $9.08 and a two-hundred day moving average of $10.28.

Institutional Trading of BGM Group

An institutional investor recently bought a new position in BGM Group stock. Marshall Wace LLP bought a new position in BGM Group Ltd. (NASDAQ:BGM) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 20,632 shares of the company’s stock, valued at approximately $218,000.

BGM Group Company Profile

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.